Diagnostic yield of routine frozen section pathology examination of lymph nodes in lung resections for clinical stage IA non–small cell lung cancer
The Journal of Thoracic and Cardiovascular Surgery · 2026
DOI: 10.1016/j.jtcvs.2025.08.031 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2026. Verfasst von Belisario A Ortiz und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minn. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Frozen Sections, Lymph Nodes. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Intraoperative identification of lymph node (LN) involvement by carcinoma has an impact on the surgical treatment of patients with clinical stage IA non-small cell lung cancer (NSCLC). This study aimed to identify the diagnostic performance of routine intraoperative frozen section pathology (FSP) evaluation of LNs in these patients. METHODS: Patients with clinical stage IA NSCLC who underwent curative-intent lung resections between 2018 and 2023 were included. Pathology reports were retrospectively reviewed for data on LN evaluation and findings from FSP and final pathology. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for the detection of node-positive disease. RESULTS: Of 1008 patients who underwent surgery during the study period, 909 (90.2%) were included in this analysis. Nodal upstaging occurred in 46 patients (5.1%), corresponding to pN1 in 31 (3.4%) and to pN2 in 15 (1.7%). FSP detected patients with node-positive disease with a sensitivity of 80.4%, specificity of 99.9%, PPV of 97.4%, and NPV of 99.0%. Of the 7016 LNs analyzed, 95 (1.4%) were involved by carcinoma on final pathology. At the LN level, FSP detected nodal disease with a sensitivity of 83.2%, specificity of 100%, PPV of 98.8%, and NPV of 99.8%. Of 565 patients with a plan to undergo sublobar resection, 556 (98.4%) had all negative LNs on FSP; only 5 (0.9%) were found to have node-positive disease on final pathology. CONCLUSIONS: FSP performs well in detecting LN metastasis intraoperatively in patients with clinical stage IA NSCLC. FSP use should be considered as sublobar resections gain widespread application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minn.
- Mayo Clinic Alix School of Medicine, Rochester, Minn.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minn.
- Division of Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minn. Electronic address: Tapias.Luis@mayo.edu.
Zitieren
APA
Ortiz, B. A., Engrav, S. K., Boland, J. M., Roden, A. C., Aubry, M. C., Abdallah, F. A., Yi, E. S., Cassivi, S. D., Wigle, D. A., Shen, K. R., Saddoughi, S. A., Reisenauer, J. S., & Tapias, L. F. (2026). Diagnostic yield of routine frozen section pathology examination of lymph nodes in lung resections for clinical stage IA non–small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2025.08.031
Vancouver
Ortiz BA, Engrav SK, Boland JM, Roden AC, Aubry MC, Abdallah FA, et al. Diagnostic yield of routine frozen section pathology examination of lymph nodes in lung resections for clinical stage IA non–small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery. 2026. doi:10.1016/j.jtcvs.2025.08.031
BibTeX
@article{Ortiz2026,
author = {Ortiz, Belisario A and Engrav, Sam K and Boland, Jennifer M and Roden, Anja C and Aubry, Marie-Christine and Abdallah, Farah A and Yi, Eunhee S and Cassivi, Stephen D and Wigle, Dennis A and Shen, K Robert and Saddoughi, Sahar A and Reisenauer, Janani S and Tapias, Luis F},
title = {Diagnostic yield of routine frozen section pathology examination of lymph nodes in lung resections for clinical stage IA non–small cell lung cancer},
journal = {The Journal of Thoracic and Cardiovascular Surgery},
year = {2026},
doi = {10.1016/j.jtcvs.2025.08.031}
}
EUVIMED